Kemal Malik
Net worth: 50 102 $ as of 31/05/2026
Net worth: 50 102 $ as of 31/05/2026
Kemal Malik currently serves as Senior Independent Director at Syncona Ltd. since 2025, Independent Director at Cartesian Therapeutics, Inc. since 2024, Member of The Royal College of Physicians, and Trustee of Our Future Health UK.
Former positions include Independent Director at Acceleron Pharma, Inc., Director & Chief Medical Officer-Pharmaceuticals at Bayer HealthCare AG, Head-Innovation & Member-Management Board at Bayer AG from 2014 to 2019, Head-Medical Affairs & Clinical Development at Bristol-Myers Squibb Pharmaceuticals Ltd., Principal at Northwick Park Institute For Medical Research, and Chief Medical Officer & Head-Global Development at Bayer Pharma AG.
Education includes an undergraduate degree from the University of London, conferred in 1987.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.02% | 14/04/2026 | 4,577 ( 0.02% ) | 34 511 $ | 31/05/2026 |
| 31/03/2025 | 11,475 ( 0% ) | 15 591 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SYNCONA LIMITED | Director/Board Member | 15/06/2020 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Our Future Health Uk
Our Future Health Uk Miscellaneous Commercial ServicesCommercial Services Provides support services | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| BAYER AG | Corporate Officer/Principal | 31/12/2019 |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Chief Tech/Sci/R&D Officer | 01/02/2014 |
| ACCELERON PHARMA INC. | Director/Board Member | - |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Northwick Park Institute For Medical Research
Northwick Park Institute For Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a charity-based independent medical research institute | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Syncona Ltd.
Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Northwick Park Institute For Medical Research
Northwick Park Institute For Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a charity-based independent medical research institute | Commercial Services |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Our Future Health Uk
Our Future Health Uk Miscellaneous Commercial ServicesCommercial Services Provides support services | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions